Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review

Arianne P. Verhagen, Aron Downie, Chris G. Maher, Bart W. Koes

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Clinicians do not want to miss underlying serious pathology, but it is still unclear which red flags are relevant. We aimed to evaluate the origin and evidence on diagnostic accuracy of red flags for malignancy for management of low back pain (LBP) in primary care. We performed a comprehensive overview and searched the literature using snowballing techniques and reference checking for evidence on red flags endorsed in clinical guidelines for identifying patients with higher likelihood of malignancy. We selected studies including people with LBP without any restriction on study design. We extracted data on prevalence and diagnostic accuracy. Furthermore, we assessed the methodological quality of studies evaluating diagnostic accuracy. We identified 13 red flags endorsed in a total of 16 guidelines and 2 extra red flags not endorsed in any guideline. We included 33 publications varying from systematic reviews to case reports. The origin of many red flags was unclear or was sourced from case reports. The incidence of malignancy in patients presenting with LBP in primary care varied between 0% and 0.7%. Seven studies provided diagnostic accuracy data on red flags. We found 5 red flags with accuracy data from 2 or more studies, with 2 (“history of malignancy” and “strong clinical suspicion”) considered informative. In conclusion, the origin and diagnostic accuracy of many red flags endorsed in guidelines are unclear. A “history of malignancy” and “strong clinical suspicion” are the only red flags with empirical evidence of acceptably high diagnostic accuracy.
LanguageEnglish
Pages1860-1868
Number of pages9
JournalPain
Volume158
Issue number10
DOIs
Publication statusPublished - Oct 2017
Externally publishedYes

Fingerprint

Low Back Pain
Guidelines
Neoplasms
Primary Health Care
Publications
Pathology
Incidence

Keywords

  • low back pain
  • clinical Guidelines
  • red flags
  • diagnostic accuracy
  • Red flags
  • Diagnostic accuracy
  • Low back pain
  • Clinical guidelines

Cite this

Verhagen, Arianne P. ; Downie, Aron ; Maher, Chris G. ; Koes, Bart W. / Most red flags for malignancy in low back pain guidelines lack empirical support : a systematic review. In: Pain. 2017 ; Vol. 158, No. 10. pp. 1860-1868.
@article{8e149667c10b4a2890f8537dc2e74536,
title = "Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review",
abstract = "Clinicians do not want to miss underlying serious pathology, but it is still unclear which red flags are relevant. We aimed to evaluate the origin and evidence on diagnostic accuracy of red flags for malignancy for management of low back pain (LBP) in primary care. We performed a comprehensive overview and searched the literature using snowballing techniques and reference checking for evidence on red flags endorsed in clinical guidelines for identifying patients with higher likelihood of malignancy. We selected studies including people with LBP without any restriction on study design. We extracted data on prevalence and diagnostic accuracy. Furthermore, we assessed the methodological quality of studies evaluating diagnostic accuracy. We identified 13 red flags endorsed in a total of 16 guidelines and 2 extra red flags not endorsed in any guideline. We included 33 publications varying from systematic reviews to case reports. The origin of many red flags was unclear or was sourced from case reports. The incidence of malignancy in patients presenting with LBP in primary care varied between 0{\%} and 0.7{\%}. Seven studies provided diagnostic accuracy data on red flags. We found 5 red flags with accuracy data from 2 or more studies, with 2 (“history of malignancy” and “strong clinical suspicion”) considered informative. In conclusion, the origin and diagnostic accuracy of many red flags endorsed in guidelines are unclear. A “history of malignancy” and “strong clinical suspicion” are the only red flags with empirical evidence of acceptably high diagnostic accuracy.",
keywords = "low back pain, clinical Guidelines, red flags, diagnostic accuracy, Red flags, Diagnostic accuracy, Low back pain, Clinical guidelines",
author = "Verhagen, {Arianne P.} and Aron Downie and Maher, {Chris G.} and Koes, {Bart W.}",
year = "2017",
month = "10",
doi = "10.1097/j.pain.0000000000000998",
language = "English",
volume = "158",
pages = "1860--1868",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "10",

}

Most red flags for malignancy in low back pain guidelines lack empirical support : a systematic review. / Verhagen, Arianne P.; Downie, Aron; Maher, Chris G.; Koes, Bart W.

In: Pain, Vol. 158, No. 10, 10.2017, p. 1860-1868.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Most red flags for malignancy in low back pain guidelines lack empirical support

T2 - Pain

AU - Verhagen, Arianne P.

AU - Downie, Aron

AU - Maher, Chris G.

AU - Koes, Bart W.

PY - 2017/10

Y1 - 2017/10

N2 - Clinicians do not want to miss underlying serious pathology, but it is still unclear which red flags are relevant. We aimed to evaluate the origin and evidence on diagnostic accuracy of red flags for malignancy for management of low back pain (LBP) in primary care. We performed a comprehensive overview and searched the literature using snowballing techniques and reference checking for evidence on red flags endorsed in clinical guidelines for identifying patients with higher likelihood of malignancy. We selected studies including people with LBP without any restriction on study design. We extracted data on prevalence and diagnostic accuracy. Furthermore, we assessed the methodological quality of studies evaluating diagnostic accuracy. We identified 13 red flags endorsed in a total of 16 guidelines and 2 extra red flags not endorsed in any guideline. We included 33 publications varying from systematic reviews to case reports. The origin of many red flags was unclear or was sourced from case reports. The incidence of malignancy in patients presenting with LBP in primary care varied between 0% and 0.7%. Seven studies provided diagnostic accuracy data on red flags. We found 5 red flags with accuracy data from 2 or more studies, with 2 (“history of malignancy” and “strong clinical suspicion”) considered informative. In conclusion, the origin and diagnostic accuracy of many red flags endorsed in guidelines are unclear. A “history of malignancy” and “strong clinical suspicion” are the only red flags with empirical evidence of acceptably high diagnostic accuracy.

AB - Clinicians do not want to miss underlying serious pathology, but it is still unclear which red flags are relevant. We aimed to evaluate the origin and evidence on diagnostic accuracy of red flags for malignancy for management of low back pain (LBP) in primary care. We performed a comprehensive overview and searched the literature using snowballing techniques and reference checking for evidence on red flags endorsed in clinical guidelines for identifying patients with higher likelihood of malignancy. We selected studies including people with LBP without any restriction on study design. We extracted data on prevalence and diagnostic accuracy. Furthermore, we assessed the methodological quality of studies evaluating diagnostic accuracy. We identified 13 red flags endorsed in a total of 16 guidelines and 2 extra red flags not endorsed in any guideline. We included 33 publications varying from systematic reviews to case reports. The origin of many red flags was unclear or was sourced from case reports. The incidence of malignancy in patients presenting with LBP in primary care varied between 0% and 0.7%. Seven studies provided diagnostic accuracy data on red flags. We found 5 red flags with accuracy data from 2 or more studies, with 2 (“history of malignancy” and “strong clinical suspicion”) considered informative. In conclusion, the origin and diagnostic accuracy of many red flags endorsed in guidelines are unclear. A “history of malignancy” and “strong clinical suspicion” are the only red flags with empirical evidence of acceptably high diagnostic accuracy.

KW - low back pain

KW - clinical Guidelines

KW - red flags

KW - diagnostic accuracy

KW - Red flags

KW - Diagnostic accuracy

KW - Low back pain

KW - Clinical guidelines

UR - http://www.scopus.com/inward/record.url?scp=85046599216&partnerID=8YFLogxK

U2 - 10.1097/j.pain.0000000000000998

DO - 10.1097/j.pain.0000000000000998

M3 - Article

VL - 158

SP - 1860

EP - 1868

JO - Pain

JF - Pain

SN - 0304-3959

IS - 10

ER -